Tor C. Olofsson

Medicon Village
Lund, M 22381, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.

Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.

Journal: The Journal of rheumatology

Published: June 15, 2026

Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.

Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.

Journal: The Journal of rheumatology

Published: June 15, 2026

Predictors of unacceptable pain and the impact of sociodemographic factors and comorbidities-results from a large, nationwide cohort of early rheumatoid arthritis.

Predictors of unacceptable pain and the impact of sociodemographic factors and comorbidities-results from a large, nationwide cohort of early rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: January 13, 2026

Axial spondyloarthritis patients with comorbid fibromyalgia feel worse, work less and more often try multiple biological therapies: results from a population-based, cross-sectional study investigating the discriminative capacity of pressure algometry.

Axial spondyloarthritis patients with comorbid fibromyalgia feel worse, work less and more often try multiple biological therapies: results from a population-based, cross-sectional study investigating the discriminative capacity of pressure algometry.

Journal: Rheumatology international

Published: December 17, 2025

Known and less well-known comorbidities in axial spondyloarthritis: what are we overlooking? Results from the SPARTAKUS cohort.

Known and less well-known comorbidities in axial spondyloarthritis: what are we overlooking? Results from the SPARTAKUS cohort.

Journal: Scandinavian journal of rheumatology

Published: September 01, 2025

SRQ - a solution for quality control, clinical decision support and research in rheumatology

SRQ - a solution for quality control, clinical decision support and research in rheumatology

Journal: Lakartidningen

Published: May 08, 2025

Gut inflammation is associated with structural spinal damage in axial spondyloarthritis - results from the observational SPARTAKUS cohort.

Gut inflammation is associated with structural spinal damage in axial spondyloarthritis - results from the observational SPARTAKUS cohort.

Journal: Arthritis research & therapy

Published: January 13, 2025

Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.

Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.

Journal: RMD open

Published: August 06, 2024

Phylogenetic characterization of Bifidobacterium kimbladii sp. nov., a novel species from the honey stomach of the honeybee Apis mellifera.

Phylogenetic characterization of Bifidobacterium kimbladii sp. nov., a novel species from the honey stomach of the honeybee Apis mellifera.

Journal: Systematic and applied microbiology

Published: May 08, 2024

Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study.

Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 15, 2024

Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.

Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.

Journal: Rheumatology (Oxford, England)

Published: March 04, 2024

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?

Journal: Scandinavian journal of rheumatology

Published: November 30, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026